Reasons underlying disparities in outcomes in liver resections between patients who are African American and patients who are not are poorly understood.
Methods—
An observational longitudinal cohort study was performed. Clinical data were collected from medical records of 166 patients (59 African American, 107 not) undergoing partial hepatectomy between 2004 and 2012. Univariate and multivariate analyses were performed.
Results—
African Americans patients undergoing partial hepatectomy were more likely to be female, heavier, have hemangiomas or adenomas, and have hepatic steatosis on explant. Intraoperatively, African Americans had longer surgical times, higher estimated blood loss, and greater use of blood products. Major postoperative complications were significantly more common in African Americans. Multivariable modeling demonstrated that race, history of hepatitis C, and estimated blood loss were the only variables that were independently associated with a major complication; however, baseline serum creatinine level was the only variable that significantly modified the effect of race on complications.
Conclusions—
African Americans with normal serum creatinine levels had a similar rate of complication to patients who were not African American, but as the baseline serum level of creatinine increased, the odds ratio for a complication developing increased dramatically in the African American patients, suggesting that the disparities seen are predominantly driven by a subset of African American patients who have preexisting renal insufficiency.
Get full access to this article
View all access options for this article.
References
1.
DimickJBCowanJAJrKnolJAUpchurchGRJr. Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a nationally representative database. Arch Surg. 2003;138(2):185–191.
2.
DimickJBWainessRMCowanJAUpchurchGRJrKnolJACollettiLM. National trends in the use and outcomes of hepatic resection. J Am Coll Surg. 2004;199(1):31–38.
3.
LucasDJSchexneiderKIWeissM. Trends and risk factors for transfusion in hepatopancreatobiliary surgery. J Gastrointest Surg. 2014;18(4):719–728. doi:10.1007/s11605-013-2417-9.
4.
CesconMVetroneGGraziGL. Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years. Ann Surg. 2009;249(6):995–1002. doi:10.1097/SLA.0b013e3181a63c74.
5.
YangTZhangJLuJHYangGSWuMCYuWF. Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases. World J Surg. 2011;35(9):2073–2082. doi:10.1007/s00268-011-1161-0.
6.
KuvshinoffBFongY. Surgical therapy of liver metastases. Semin Oncol. 2007;34(3):177–185.
7.
PawlikTMChotiMA. Surgical therapy for colorectal metastases to the liver. J Gastrointest Surg. 2007;11(8):1057–1077.
8.
JanTMedvedevSCannonRM. Racial disparity and their impact on hepatocellular cancer outcomes in inner-city New Orleans. Surgery. 2012;152(4):661–666; discussion 666–667. doi:10.1016/j.surg.2012.07.008.
9.
PalanisamyAPSchiltzCE3rdPilchNA. Cardiovascular risk factors contribute to disparities in graft outcomes in African American renal transplant recipients: a retrospective analysis. Blood Press. 2014:1–9.
10.
RangrassGGhaferiAADimickJB. Explaining racial disparities in outcomes after cardiac surgery: the role of hospital quality. JAMA Surg. 2014;149(3):223–227.
11.
NoureldineSIAbbasATufanoRPSrivastavSSlakeyDPFriedlanderPKandilE. The impact of surgical volume on racial disparity in thyroid and parathyroid surgery. Ann Surg Oncol. 2014;21(8):2733–2739. doi:10.1245/s10434-014-3610-0.
12.
NguyenGCPatelAM. Racial disparities in mortality in patients undergoing bariatric surgery in the U.S.A.Obes Surg. 2013;23(10):1508–1514. doi:10.1007/s11695-013-0957-4.
13.
AizerAAWilhiteTJChenMH. Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period. Cancer. 2014;120(10):1532–1539.
14.
ZakYRhoadsKFVisserBC. Predictors of surgical intervention for hepatocellular carcinoma: race, socioeconomic status, and hospital type. Arch Surg. 2011;146(7):778–784.
15.
SonnendayCJDimickJBSchulickRDChotiMA. Racial and geographic disparities in the utilization of surgical therapy for hepatocellular carcinoma. J Gastrointest Surg. 2007;11(12):1636–1646; discussion 1646.
16.
SloaneDChenHHowellC. Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival. J Natl Med Assoc. 2006;98(12):1934–1939.
17.
OsborneNHUpchurchGRJrMathurAKDimickJB. Explaining racial disparities in mortality after abdominal aortic aneurysm repair. J Vasc Surg. 2009;50(4):709–713.
18.
LucasFLStukelTAMorrisAMSiewersAEBirkmeyerJD. Race and surgical mortality in the United States. Ann Surg. 2006;243(2):281–286.
19.
JarnaginWRGonenMFongY. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg. 2002;236(4):397–406; discussion 406–397.
20.
WiggansMGShahtahmassebiGBowlesMJArooriSStellDA. Renal dysfunction is an independent risk factor for mortality after liver resection and the main determinant of outcome in posthepatectomy liver failure. HPB Surg. 2013;2013:875367. doi:10.1155/2013/875367.
21.
BehrnsKETsiotosGGDeSouzaNFKrishnaMKLudwigJNagorneyDM. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg. 1998;2(3):292–298.
22.
MathurAKOsborneNHLynchRJGhaferiAADimickJBSonnendayCJ. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma. Arch Surg. 2010;145(12):1158–1163. doi:10.1001/archsurg.2010.272.
23.
NathanHFrederickWChotiMASchulickRDPawlikTM. Raical disparity in surgical mortality after major hepatectomy. J Am Coll Surg. 2008;207:312–319.
24.
SquiresMH3rdMehtaVVFisherSB. Effect of preoperative renal insufficiency on postoperative outcomes after pancreatic resection: a single institution experience of 1,061 consecutive patients. J Am Coll Surg. 2014;218(1):92–101. doi:10.1016/j.jamcollsurg.2013.09.012.
25.
ArmstrongTWelshFKWellsJChandrakumaranKJohnTGReesM. The impact of pre-operative serum creatinine on short-term outcomes after liver resection. HPB (Oxford). 2009;11(8):622–628. doi:10.1111/j.1477-2574.2009.00094.x.
26.
ChengSBWuCCShuKH. Liver resection for hepatocellular carcinoma in patients with end-stage renal failure. J Surg Oncol. 2001;78(4):241–246; discussion 246–247.
27.
OriiTTakayamaTHagaIFukumoriTAmadaN. Efficacy of a liver resection for hepatocellular carcinoma in patients with chronic renal failure. Surg Today. 2008;38(4):329–334. doi:10.1007/s00595-007-3634-1.
28.
YehCNLeeWCChenMF. Hepatic resection for hepatocellular carcinoma in end-stage renal disease patients: two decades of experience at Chang Gung Memorial Hospital. World J Gastroenterol. 2005;11(14):2067–2071.
29.
ToshimaTShirabeKYoshiyaS. Outcome of hepatectomy for hepatocellular carcinoma in patients with renal dysfunction. HPB (Oxford). 2012;14(5):317–324.
30.
ChoiAIRodriguezRABacchettiPBertenthalDHernandezGTO'HareAM. White/black racial differences in risk of end-stage renal disease and death. Am J Med. 2009;122(7):672–678. doi:10.1016/j.amjmed.2008.11.021.
31.
Tarver-CarrMEPoweNREberhardtMS. Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors. J Am Soc Nephrol. 2002;13(9):2363–2370.
32.
KlagMJWheltonPKRandallBLNeatonJDBrancatiFLStamlerJ. End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA. 1997;277(16):1293–1298.
